Here are six things to know.
1. California regulators issued the order Feb. 28 after an inspection by the state pharmacy board found multiple violations of federal law, including failing to test the components of each medication and improperly labeling drugs. In addition, the inspection found Pharmedium Services didn’t use “sound scientific support” to assign expiration dates for compounded medicine, according to STAT.
2. A cease-and-desist order is rare in California for pharmaceutical companies, according to the report. It is handed down by a government agency or court and forces a person or entity to stop what they are doing immediately.
3. According to the order, the compounder was given numerous opportunities to fix the problems, but the violations persisted.
4. The infractions may jeopardize a key license the company holds in Texas that allows it to ship drugs from a facility in Texas to California. The license to ship to California is held by its outsourcing facility in Texas that makes bulk supplies.
5. The cease-and-desist order expires after 30 days; however, this key license that allows it to ship items to California expires on March 31 and it is unclear when the issue will be resolved.
6. A spokesperson for AmerisourceBergen told STAT, “Pharmedium is actively evaluating our position with the California State Board of Pharmacy. We remain committed to promptly resolving this issue.”
More articles on supply chain:
Survey: Top healthcare supply chain priorities in 2018
Trump: Stay tuned for federal action on high drug prices
Intermountain, SSM, Ascension and Trinity’s generic drug venture could have a third of the hospital market as members: 6 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.